Brand Institute

Executive Summary

Brand Institute is the world's leading strategic branding and nomenclature consultancy for the pharmaceutical and healthcare industries. Founded in 1993 and headquartered in Miami, the company provides end-to-end services from name development and trademark screening to regulatory safety research and visual identity design. It holds a dominant market share in prescription drug name approvals globally, aided by a unique business model that employs former regulatory agency officials to ensure high compliance and success rates. As a private, self-funded company with no disclosed funding rounds, Brand Institute has maintained a steady, profitable operation without external capital. Its deep expertise and regulatory relationships create significant competitive moats, making it a resilient player in the niche but essential drug naming space.

Upcoming Catalysts (preview)

• H2 2026Potential New FDA Guidance on Drug Nomenclature60% success
• 2027Expansion into Biosimilar and Gene Therapy Naming50% success
• TBDStrategic Acquisition or Partnership to Enhance Digital Capabilities30% success